Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ana M. Benedicto"'
Autor:
Ana M. Benedicto, Federico Lucantoni, Isabel Fuster-Martínez, Pedro Diaz-Pozo, Dimitri Dorcaratto, Elena Muñoz-Forner, Victor M. Victor, Juan V. Esplugues, Ana Blas-García, Nadezda Apostolova
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 178, Iss , Pp 117206- (2024)
Activated hepatic stellate cells (aHSCs), the main perpetrators of liver fibrosis, are a promising therapeutic target in the treatment of chronic liver disease. During liver injury, HSCs transcend from a quiescent to a fibrotic phenotype, a process w
Externí odkaz:
https://doaj.org/article/4566746598384a248dc57308c0adc8a0
Autor:
Angela B. Moragrega, Aleksandra Gruevska, Isabel Fuster-Martínez, Ana M. Benedicto, Joan Tosca, Cristina Montón, Victor M. Victor, Juan V. Esplugues, Ana Blas-García, Nadezda Apostolova
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 167, Iss , Pp 115537- (2023)
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease (CLD) worldwide and inflammation is key to its progression/resolution. As we have previously described that rilpivirine (RPV) is hepatoprotective in murine mo
Externí odkaz:
https://doaj.org/article/2a96dfa401664d44b04a36bbadd0858b
Autor:
Federico Lucantoni, Ana M. Benedicto, Aleksandra Gruevska, Ángela B. Moragrega, Isabel Fuster-Martínez, Juan V. Esplugues, Ana Blas-García, Nadezda Apostolova
Publikováno v:
Cell Death and Disease, Vol 13, Iss 4, Pp 1-13 (2022)
Abstract As the main extracellular matrix-producing cells, activated hepatic stellate cells (HSC) are fundamental mediators of liver fibrosis (LF), and understanding their activation/inactivation mechanisms is paramount to the search for novel therap
Externí odkaz:
https://doaj.org/article/1d240ae1bdbc46d6abc032ee8500c9e5
Autor:
Ana M. Benedicto, Isabel Fuster-Martínez, Joan Tosca, Juan V. Esplugues, Ana Blas-García, Nadezda Apostolova
Publikováno v:
Cells, Vol 10, Iss 7, p 1687 (2021)
Due to the improved effectiveness and safety of combined antiretroviral therapy, human immunodeficiency virus (HIV) infection has become a manageable, chronic condition rather than a mortal disease. However, HIV patients are at increased risk of expe
Externí odkaz:
https://doaj.org/article/e2298057caf64ae99d7a3586d8b9bac3
Autor:
Nadezda Apostolova, Juan V. Esplugues, Ana Blas-Garcia, Isabel Fuster-Martínez, Joan Tosca, Ana M Benedicto
Publikováno v:
Cells
Cells, Vol 10, Iss 1687, p 1687 (2021)
Cells, Vol 10, Iss 1687, p 1687 (2021)
Due to the improved effectiveness and safety of combined antiretroviral therapy, human immunodeficiency virus (HIV) infection has become a manageable, chronic condition rather than a mortal disease. However, HIV patients are at increased risk of expe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::382527047c21699ca7d64f387f5e0da7
https://pubmed.ncbi.nlm.nih.gov/34359857
https://pubmed.ncbi.nlm.nih.gov/34359857